Weight Gain Limitation and Liver Protection by Long-Term Feeding of Astaxanthin in Murines

Hepatocyte protection by astaxanthin (100 mg/kg feed for 4 wk with rats) was tested with CCl₄ (0.2 mL/100 g weight). The liver catalase and the lipid peroxide contents of the control, CCl₄, treated, and CCl₄ + astaxanthin treated rats were 17.1, 30.1, and 26.1 mmol/mg protein/min and 1.23, 1.74, and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Applied biological chemistry 2009, 52(2), , pp.180-185
Hauptverfasser: Kim, S.H., Chungnam National University, Daejeon, Republic of Korea, Jean, D.I., Chungnam National University, Daejeon, Republic of Korea, Lim, Y.P., Chungnam National University, Daejeon, Republic of Korea, Lee, C.Y., Daejeon University, Daejeon, Republic of Korea, An, G.H., Chungnam National University, Daejeon, Republic of Korea
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Hepatocyte protection by astaxanthin (100 mg/kg feed for 4 wk with rats) was tested with CCl₄ (0.2 mL/100 g weight). The liver catalase and the lipid peroxide contents of the control, CCl₄, treated, and CCl₄ + astaxanthin treated rats were 17.1, 30.1, and 26.1 mmol/mg protein/min and 1.23, 1.74, and 1.51 μmol/g liver, respectively. These data indicated that astaxanthin attenuated the adverse effect of CCl₄. The effect of astaxanthin [300 mg/kg in normal feed for 44 weeks and high-fat feed (10% lard oil, w/w) for the next 26 weeks] on the weight gain was investigated. With the feed of chemically synthesized astaxanthin, the weight increase was significantly slow in the male mice, but not in the females. Chemical astaxanthin decreased the levels of blood glucose, cholesterol, and triglyceride in mice by 4-21%, suggesting astaxanthin can be used to protect hepatocytes and cardiovascular system, and to limit weight gain caused by a high lipid consumption.
ISSN:1738-2203
2468-0834
2234-344X
2468-0842
DOI:10.3839/jksabc.2009.033